ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Håkon Håkonarson, Michael March et al.|Nature Medicine|2019Cited by 221
Genomic profiling informs diagnoses and treatment in vascular anomaliesDong Li, Håkon Håkonarson, Sarah E. Sheppard et al.|Nature Medicine|2023Cited by 63
Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibitionSarah E. Sheppard, Håkon Håkonarson, Michael March et al.|JCI Insight|2023Cited by 37
Heterozygous rare variants in NR2F2 cause a recognizable multiple congenital anomaly syndrome with developmental delaysMythily Ganapathi, Elizabeth Bhoj, Lisa Bastarache et al.|European Journal of Human Genetics|2023Cited by 25
Pathogenic variants in CDH11 impair cell adhesion and cause Teebi hypertelorism syndromeDong Li, Elizabeth Bhoj, Michael March et al.|Human Genetics|2021Cited by 8